Lawson Health Research Institute Receives Funding to Develop Non-Reactor Based Isotopes

Jan 24, 2011,  LONDON, Ontario – Lawson Health Research Institute has been awarded approximately $1.5 million by Natural Resources Canada to develop the capability of producing Technetium-99m (Tc-99m). The intent is to produce the radioisotope on Lawson’s new medical cyclotron at the Nordal Cyclotron & PET Radiochemistry Facility in sufficient commercial quantities to supply London, Ontario and the surrounding area with this vital medical radioisotope.

Natural Resources Canada announced today that Lawson, together with Hamilton-based Centre for Probe Development & Commercialization  and Vancouver-based TRIUMF and the BC Cancer Agency, will receive a total of $6 million for the project entitled "A Collaborative Program for the Production of Tc-99m Using Medical Cyclotrons”. More....